Ads
related to: newest rheumatoid arthritis treatment drugs- Monotherapy Option
Learn About A Monotherapy
Treatment Option For RA.
- Financial Support
Financial Support Information
For Your RA Patients.
- Multiple Dosing Methods
Learn About Which Administration
Method May Help Your RA Patient.
- Patient Support Services
Access Helpful Forms and Documents
For Your Patients.
- Clinical Studies
View The Established Clinical Trial
Info For An RA Treatment Option.
- Coverage Map For HCPs
Fill Out Form To Request
A Coverage Map.
- Monotherapy Option
Search results
Results From The WOW.Com Content Network
Adalimumab, sold under the brand name Humira and others, is a disease-modifying antirheumatic drug and monoclonal antibody used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.
Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome, COVID‑19, and systemic sclerosis-associated interstitial lung disease (SSc-ILD).
Conventional DMARDs are known to be the first-line treatment for rheumatoid arthritis. [9] Treatment can be a monotherapy or in combination with other anti-arthritic medications. Common DMARDs include oral methotrexate, leflunomide, or sulfasalazine. Conventional DMARDs have a slow onset of action and can take 2–3 months to exhibit effect. [9]
Shares of Antares Pharma , a developer of auto injectors and topical gel treatments, rallied on Monday after the company announced that the Food and Drug Administration had approved its Otrexup ...
Filgotinib, sold under the brand name Jyseleca, is a medication used for the treatment of rheumatoid arthritis (RA). [3] It was developed by the Belgian-Dutch biotech company Galapagos NV. [6] The most common side effects include nausea (feeling sick), upper respiratory tract infection (nose and throat infection), urinary tract infection and ...
Baricitinib, sold under the brand name Olumiant among others, is an immunomodulatory medication used for the treatment of rheumatoid arthritis, alopecia areata, and COVID-19.
Ads
related to: newest rheumatoid arthritis treatment drugs